Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

KNT 127

Known as: KNT-127, KNT127 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Strategies to facilitate extinction of fear memory have attracted increasing attention for enhancing the effectiveness of… Expand
Is this relevant?
2018
2018
RationaleWe previously reported that systemic administration of a selective delta opioid receptor (DOP) agonist, KNT-127… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2017
2017
We previously demonstrated that a single treatment of a non-peptidic delta opioid receptor agonist, KNT-127, has an… Expand
Is this relevant?
2016
2016
BACKGROUND AND PURPOSE δ Opioid receptor agonists are being developed as potential treatments for depression and alcohol use… Expand
Is this relevant?
2014
2014
Recently, we reported that the δ opioid receptor (DOR) agonist KNT-127 produces anxiolytic-like effects in behaving rats. Here… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2014
2014
BACKGROUND AND PURPOSE Activation of δ opioid (DOP) receptors regulates pain and emotional responses, and also displays ligand… Expand
Is this relevant?
2013
2013
We previously reported that a δ opioid receptor agonist SNC80 produced potent anxiolytic-like effects in rodents. Recently, we… Expand
Is this relevant?
2012
2012
The effects of systemic δ1-agonist on neurotransmission remains obscure, since no selective δ1-agonist exists that can penetrate… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
We previously reported that the δ opioid receptor (DOP) agonists SNC80 and TAN-67 produce potent antidepressant-like and… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 5
Is this relevant?
2010
2010
We have reported previously the novel δ-opioid agonist, SN-28, which was more potent in in vitro assays than the prototype… Expand
Is this relevant?